H. M. Arrighi, E. J. Metter, H. A. Guess and J. L. Fozzard, “Natural History of Benign Prostatic Hyperplasia and Risk of Prostatectomy: The Baltimore Longitudinal Study of Aging,” Urology, Vol. 38, No. 1, 1991, pp. 4-8.
 M. T. Rosenberg, D. R. Staskin, S. A. Kaplan, S. A. MacDiarmid, D. K. Newman and D. A. Ohl, “A Practical Guide to the Evaluation and Treatment of Male Lower Urinary Tract Symptoms in the Primary Care Setting,” International Journal of Clinical Practice, Vol. 61, 2007, pp. 1535-1546.
 AUA Practice Guidelines Committee, “AUA Guideline on Management of Benign Prostatic Hyperplasia: Diagnosis and Treatment Recommendations,” Chapter 1, 2003, pp. 1-11. http://professional.medtronic.com
 C. G. Roehrborn, “The Potential of Serum Prostate-Specific Antigen as a Predictor of Clinical Response in Patients with Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia,” British Journal of Urology International, Vol. 93, 2004, pp. 21-26.
 J. A. Schalken, “Molecular and Cellular Prostate Biology: Origin of Prostate-Specific Antigen Expression and Implications for Benign Prostatic Hyperplasia,” British Journal of Urology International, Vol. 93, 2004, pp. 5-9.
 C. R. Chapple, “Pharmacological Therapy of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms: An Overview for the Practising Clinician,” British Journal of Urology International, Vol. 94, 2004, pp. 738-744.
 G. Maria, G. Brisinda, I. M. Civello, A. R. Bentivoglio, G. Sganga and A. Albanese, “Relief by Botulinum Toxin of Voiding Dysfunction Due to Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled Study Giorgio,” Urology, Vol. 62, No. 2, 2003, pp. 259-265.
 G. L. Lu-Yao, M. J. Barry, C. H. Chang, et al., “For the Prostate Patient Outcomes Research Team (PORT): Transurethral Resection of the Prostate among Medicare Beneficiaries in the United States: Time Trends and Outcomes,” Urology, Vol. 44, 1994, pp. 692-698.
 Operational Guidance, “Information Needed to Support Clinical Trials of Herbal Products,” World Health Organization on Behalf of the Special Programme for Research and Training in Tropical Diseases, 2005, TDR/GEN/Guidance/05.1.
 J. D. McConnell, M. J. Barry and R. C. Bruskewitz, “Benign Prostatic Hyperplasia: Diagnosis and Treatment (Clinical Practice Guideline No. 8),” In: M. D. Rockville, Ed., Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1994.
 G. Bartsch, R. S. Rittmaster and H. Klocker, “Dihydro-testosterone and the Concept of 5Alpha-Reductase Inhibition in Human Benign Prostatic Hyperplasia,” World Journal of Urology, Vol. 19, 2002, pp. 413-425.
 V. N. Pandey, “Pharmacological investigations of Certain Medicinal Plants & Compound Formulations Used in Ayurveda & Siddha,” 1st Edition, CCRAS, Department of ISM & H. Govt. of India, New Delhi, 1996, pp. 69-72.
 M. A. Momoh and M. U. Adikwu, “Evaluation of the Effect of Colloidal Silver on the Antibacterial Activity of Ethanolic Extract of Lichen Parmelia perlata,” African Journal of Pharmacy Pharmacology, Vol. 2, No. 6, 2008, pp. 106-109.
 A. B. Gokhale, A. S. Damre, K. R. Kulkami and M. N. Saraf, “Preliminary Evaluation of Anti-Inflammatory and Anti-Arthritic Activity of S. lappa, A. speciosa and A. aspera,” Phytomedicine, Vol. 9, No. 5, 2002, 433-437.
 C. H. Hong, S. K. Hur, O. J. Oh, S. S. Kim, K. A. Nam and S. K. Lee, “Evaluation of Natural Products on Inhibition of Inducible Cyclooxygenase (COX-2) and Nitric Oxide Synthase (iNOS) in Cultured Mouse Macrophage Cells,” Journal of Ethnopharmacology, Vol. 83, No. 1-2, 2002, pp. 153-159.
 G. L. Hammond, O. Lukkarinen, P. Vihko, M. Kontturi and R. Vihko, “The Hormonal Status of Patients with Benign Prostatis Hypertrophy: FSH, LH, TSH and Prolactin Responses to Releasing Hormones,” Clinical Endocrinology, Vol. 10, No. 6, 1979, pp. 545-552.
 M. L Kuhut, et al., “Ingestion of a Dietary Supplement Containing Dehydroepiandrosterone (DHEA) and Androstenedione Has Minimal Effect on Immune Function in Middle-Aged Men,” Journal of the American College of Nutrition, Vol. 22, No. 5, 2003, pp. 363-371.
 F. M Parabia, et al., “Effect of Plant Growth Regulators on in Vitro Morphogenesis of Leptadenia reticulata (Retz.) W and A. from Nodal Explants,” Current Sciences, Vol. 92, No. 9, 2007, pp. 1290-1293.